PharmaCyte Biotech, Inc. Common Stock (NASDAQ: PMCB) last traded at $0.365, down 9.72% on the session. The quote above updates while this page is open; the figures below are drawn from PharmaCyte Biotech, Inc. Common Stock’s own filings and are restated only when a new one is published.
PharmaCyte Biotech, Inc. Common Stock trades on NASDAQ under the ticker PMCB. Its market capitalisation is $3.92 million.
Valuation measures for PharmaCyte Biotech, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.92M |
|---|---|
| Enterprise value | -$6.92M |
| Price / book | 0.14 |
| Beta | 1.78 |
Trailing-twelve-month figures tagged in PharmaCyte Biotech, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$16.15M |
|---|
| Return on equity | -58.69% |
|---|
| Cash | $17.74M |
|---|
Range and volume for PMCB over the past 52 weeks.
| 52-week high | $1.51 |
|---|---|
| 52-week low | $0.334 |
| Volume | 116.9K |
| Average volume | 205.0K |
| Previous close | $0.404 |
Invest a chosen dollar amount in PharmaCyte Biotech, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PMCB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.